BSc and PhD Molecular Biology
Our Team
James Miskin
Fractional Chief Technology Officer and Non-Executive Director
Quote from James...
"I’m looking forward to supporting eXmoor as it continues to expand its GMP operations and help clients navigate the path to commercialisation. It’s an exciting time for the cell and gene therapy sector, and eXmoor has a key role to play."
About James
James brings more than two decades of leadership experience in cell and gene therapy, with deep expertise in the design, development, manufacturing and testing of viral vectors for clinical and commercial use.
Prior to joining eXmoor, he spent over 23 years at Oxford Biomedica, where he held senior executive roles including Chief Technical Officer and, most recently, Chief Quality and Technical Officer.
Throughout his career, James has led cross-functional teams across GMP manufacturing, process development, quality, regulatory affairs and strategic programme management. He is a named inventor on several patents in the field and is the founding director of the BBSRC-funded ABViP programme – a collaborative training partnership with the University of Oxford and University College London. He continues to support a range of organisations as an independent consultant.
At eXmoor Pharma, James serves as a Non-Executive Director and fractional Chief Technology Officer, working closely with the leadership team to shape technical direction and capability across the business.
Let’s Accelerate Your Therapy Together
Whether you're in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.